1 / 13

GRADING AND STAGING OF TUMORS

Nikola Blažević Mentor: A. Žmegač Horvat. GRADING AND STAGING OF TUMORS. GRADING. Degree of maturity or differentiation under the microscope Histologic grade – resemblance between tumor and normal cells Nuclear grade – size and shape of nucleus, dividing cells

dominickl
Télécharger la présentation

GRADING AND STAGING OF TUMORS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Nikola Blažević Mentor: A. Žmegač Horvat GRADING AND STAGING OF TUMORS

  2. GRADING Degree of maturity or differentiation under the microscope Histologic grade – resemblance between tumor and normal cells Nuclear grade – size and shape of nucleus, dividing cells Carcinoma,adrenal gland

  3. How is tumor grade determined? • Biopsy – benign or malignant - pathologist – level of differentiation • http://www.youtube.com/watch?v=Ms4b7eGLtf8&feature=related

  4. TUMORGRADES • Microscopic apperance of cancer cells • 4 degrees of severity • Grade: GX Grade cannot be assessed (Undetermined grade) G1Well-differentiated (Low grade) G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade)

  5. GRADING SYSTEMS Different for different types of cancers Gleason – prostate cancer Bloom-Richardson – breast cancer Fuhrman – kidney cancer Gleason system Fuhrman system

  6. GRADING – TREATMENT • For treatment and prognosis • Lower grade  better prognosis (outcome of diease) • Higher grade  worse prognosis • Important in treatment of  prim. brain tumors (astrocytomas) lymphomas breast cancer prostate

  7. STAGING • Extent of the prim. tumor and extent of spread in the body • Important - helps planning treatment - helps estimating prognosis - helps identifying clinical trials

  8. STAGING SYSTEMS • No unique staging system • Common elements : - Location of the primary tumor - Tumor size and number of tumors - Lymph node involvement (spread of cancer into lymph nodes) - Cell type and tumor grade (how closely the cancer cells resemble normal tissue) - Presence or absence of metastasis

  9. TNM - system • Most common (accepted by UICC, AICC) • Based on : T extent of the tumor Nextent of spread to the lymph nodes M presence of metastasis • Number indicates size or extent of the prim. tumor and the extent of spread of metastasis

  10. Primary Tumor (T) TX Primary tumor cannot be evaluated T0 No evidence of primary tumor Tis Carcinoma in situ (has not spread) T1, T2, T3, T4 Size and/or extent of the primary tumor Regional Lymph Nodes (N) NXRegional lymph nodes cannot be evaluated N0 No regional lymph node involvement N1, N2, N3 Involvement of regional lymph nodes (number and/or extent of spread) Distant Metastasis (M) MX Distant metastasis cannot be evaluated M0 No distant metastasis M1 Distant metastasis (cancer has spread to distant parts of the body)

  11. OTHER CLASSIFICATION Ann Arbour  lymphomas Duke’s classification  colon cancer Breslow scale and Clark’s level  melanoma

  12. DETERMINATION OF STAGES Physical exams  examination, looking, listening Imaging studies X-ray, US, CT, MRI, PET Laboratory tests  blood, urine, AST/ALT, tumor markers (CA19-9,CA19-5….) Pathology reports  biopsy, cytology Surgical reports Lung cancer,PET scan

  13. References • http://www.cancer.gov/ • www.wikipedia.com • Oxford handbook of clinical medicine,Murray Longmore

More Related